Literature DB >> 4344732

The effect of sulfonylurea drugs on rabbit myocardial contractility, canine purkinje fiber automaticity, and adenyl cyclase activity from rabbit and human hearts.

K C Lasseter, G S Levey, R F Palmer, J S McCarthy.   

Abstract

Long-term clinical studies have associated tolbutamide therapy with an increased incidence of cardiovascular deaths. The effects of this and other sulfonylurea drugs on contractility and rate of isolated rabbit atria, automaticity of isolated dog Purkinje fibers, and adenyl cyclase activity in particulate preparations of rabbit and human hearts were studied. At concentrations that are attained clinically, tolbutamide (10 mg/100 ml) increased contractility of driven rabbit atria to 124+/-5% of control, acetohexamide (3.9 mg/100 ml) to 140+/-5%, chlorpropamide (8.3 mg/100 ml) to 139+/-6%, and tolazamide (3.1 mg/100 ml) to 119+/-6%. These effects were accentuated in the presence of 2.5 x 10(-4) M theophylline and were not blocked by 1 x 10(-5) M propranolol. Adenyl cyclase was activated by each of these drugs at concentrations below those which increase contractility. The drugs also increased the rate and slope of phase 4 depolarization in spontaneously beating Purkinje fibers, but did not alter the spontaneous rate of isolated rabbit atria. Since inotropic and chronotropic stimulation can be deleterious in some clinical settings, these findings may be of significance in interpretation of cardiovascular mortality data.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4344732      PMCID: PMC292411          DOI: 10.1172/JCI107056

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  20 in total

1.  Tolbutamide: an inotropic effect on rabbit atria.

Authors:  R F Palmer; K C Lasseter; J McCarthy
Journal:  Lancet       Date:  1971-03-20       Impact factor: 79.321

2.  A simple, sensitive method for the assay of adenyl cyclase.

Authors:  G Krishna; B Weiss; B B Brodie
Journal:  J Pharmacol Exp Ther       Date:  1968-10       Impact factor: 4.030

3.  Activation of adenyl cyclase by glucagon in cat and human heart.

Authors:  G S Levey; S E Epstein
Journal:  Circ Res       Date:  1969-02       Impact factor: 17.367

4.  Hydrodynamic forces in dissecting aneurysms. In-vitro studies in a Tygon model and in dog aortas.

Authors:  E K Prokop; R F Palmer; M W Wheat
Journal:  Circ Res       Date:  1970-07       Impact factor: 17.367

5.  Factors influencing infarct size following experimental coronary artery occlusions.

Authors:  P R Maroko; J K Kjekshus; B E Sobel; T Watanabe; J W Covell; J Ross; E Braunwald
Journal:  Circulation       Date:  1971-01       Impact factor: 29.690

6.  Studies on digitalis. XVI. Effects on myocardial oxygen consumption.

Authors:  J W Covell; E Braunwald; J Ross; E H Sonnenblick
Journal:  J Clin Invest       Date:  1966-10       Impact factor: 14.808

7.  Myocardial adenyl cyclase: activation by thyroid hormones and evidence for two adenyl cyclase systems.

Authors:  G S Levey; S E Epstein
Journal:  J Clin Invest       Date:  1969-09       Impact factor: 14.808

8.  Activation of myocardial adenyl cyclase by histamine in guinea pig, cat, and human heart.

Authors:  I Klein; G S Levey
Journal:  J Clin Invest       Date:  1971-05       Impact factor: 14.808

9.  A protein binding assay for adenosine 3':5'-cyclic monophosphate.

Authors:  A G Gilman
Journal:  Proc Natl Acad Sci U S A       Date:  1970-09       Impact factor: 11.205

10.  Control of myocardial oxygen consumption: relative influence of contractile state and tension development.

Authors:  T P Graham; J W Covell; E H Sonnenblick; J Ross; E Braunwald
Journal:  J Clin Invest       Date:  1968-02       Impact factor: 14.808

View more
  15 in total

1.  Diabetic hearts and biguanides.

Authors:  P Biron
Journal:  Can Med Assoc J       Date:  1975-08-09       Impact factor: 8.262

2.  Letter: Phenformin and the heart.

Authors:  P Biron
Journal:  Can Med Assoc J       Date:  1976-01-24       Impact factor: 8.262

3.  Editorial: Diabetic hearts and biguanides-a reply.

Authors:  N W Rodger
Journal:  Can Med Assoc J       Date:  1976-09-04       Impact factor: 8.262

Review 4.  Oral hypoglycaemic drugs: clinical pharmacology and therapeutic use.

Authors:  J M Stowers; L J Borthwick
Journal:  Drugs       Date:  1977-07       Impact factor: 9.546

5.  The direct effect of hypoglycaemic sulphonylureas on myocardial contractile force and arterial blood pressure.

Authors:  G Pogátsa; E Dubecz
Journal:  Diabetologia       Date:  1977-09       Impact factor: 10.122

Review 6.  Defective oxidation of drugs: pharmacokinetic and therapeutic implications.

Authors:  M Eichelbaum
Journal:  Clin Pharmacokinet       Date:  1982 Jan-Feb       Impact factor: 6.447

Review 7.  Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2.

Authors:  J E Jackson; R Bressler
Journal:  Drugs       Date:  1981-10       Impact factor: 9.546

Review 8.  Drug-induced taste and smell disorders. Incidence, mechanisms and management related primarily to treatment of sensory receptor dysfunction.

Authors:  R I Henkin
Journal:  Drug Saf       Date:  1994-11       Impact factor: 5.606

9.  Direct effect of glibenclamide on guanylate cyclase activity in the rat in vitro.

Authors:  D L Vesely
Journal:  Diabetologia       Date:  1982-04       Impact factor: 10.122

10.  Effects of midaglizole, a new hypoglycaemic drug on the electrophysiological properties of guinea-pig papillary muscle.

Authors:  N Noguchi; J Hasegawa; H Mashiba
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.